
Compugen
Develops and commercializes novel drug candidates for oncology and immunology.
About
Compugen is a clinical-stage drug discovery and development company focused on identifying and developing novel drug candidates for oncology and immunology. They utilize their proprietary discovery platforms to identify new biological targets and develop innovative therapies for unmet medical needs.
Similar companies
Cloud computing, IT consulting, and managed IT services for businesses in Toronto, Vancouver, and Burnaby.
In IT Consulting
Full-service IT support and consulting specializing in network design, implementation, and support.
In IT Support
Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
Shares Oncology, Life Sciences
Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.
Shares Immunology, Life Sciences
AI-driven drug discovery platform accelerating breakthrough scientific research.
Shares Drug Discovery, Life Sciences
A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.
Shares Life Sciences, HealthTech
Key facts
- Website
- cgen.com
- Headquarters
- Tel Aviv, Israel
- Founded
- 1993
- Employees
- 112
- Total funding
- $102M (Funding Round)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Post-money | Lead investors |
|---|---|---|---|---|
| 11 Nov 2021 | Funding Round | $20M | Bristol-Myers Squibb | |
| 11 Oct 2018 | Funding Round | $12M | Bristol-Myers Squibb | |
| 30 Dec 2009 | Undisclosed round | $20M | Cantor Fitzgerald | |
| 12 Jul 2000 | Funding Round | $35M | $150M | |
| 18 Dec 1998 | Undisclosed round | $15M | $55M |
Tech stack
Detected on cgen.com, last scanned 5 Nov 2026. Run your own scan
- CDN
- Cloudflare
- Email provider
- Microsoft 365
Test your Ahrefs DR
The backlink strength of a domain, on the Ahrefs 0 to 100 scale. About a minute.
1 review from Reddit gathered in one place
Compugen Ltd. reported strong fourth quarter and full year 2025 financial results, driven by a $65 million non-dilutive royalty monetization deal with AstraZeneca that extends its cash runway into 2029.
Each quote is copied word for word and links to where it was posted. Promotion and off-topic posts are filtered out.
Frequently asked
Is Compugen trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Compugen is 89 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has Compugen raised?
Compugen has raised a total of $102M in funding. The most recent round on record is Funding Round.
How many employees does Compugen have?
Compugen has approximately 112 people on record.
SEC filings, insider activity, nonprofit links and pay benchmarks for Compugen:
Company details: from public sources. Funding: no announced round on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules


